Clinical Trial Update: Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial is evaluating LC-K76 for safety and efficacy in metastatic prostate cancer. The study targets metastatic hormone-sensitive and metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-naïve Prostate Cancer
• Hormone-sensitive Prostate Cancer

Drugs mentioned

• LC-K76 (LC-K76)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: mHSPC, mHNPC | EARLY_Phase 1 | Status: NOT_YET_RECRUITING